Clinical trials
Diabetes Complications trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 5 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aroa Biosurgery Limited | 2 |
| Samaritan Biologics | 2 |
| VA Office of Research and Development | 2 |
| Albert Einstein College of Medicine | 1 |
| Amalgam Rx, Inc. | 1 |
| Axolotl Biologix | 1 |
| B. Braun Medical Inc. | 1 |
| Boston Medical Center | 1 |
| C5 Biomedical | 1 |
| Casa Colina Hospital and Centers for Healthcare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Complications | 32 |
| Diabetes Mellitus | 15 |
| Diabetic Foot | 12 |
| Diabetes Mellitus, Type 2 | 8 |
| Foot Ulcer | 8 |
| Leg Ulcer | 7 |
| Skin Ulcer | 5 |
| Diabetic Angiopathies | 4 |
| Diabetic Neuropathies | 4 |
| Ulcer | 4 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.